FR2100660A1 - - Google Patents

Info

Publication number
FR2100660A1
FR2100660A1 FR7117104A FR7117104A FR2100660A1 FR 2100660 A1 FR2100660 A1 FR 2100660A1 FR 7117104 A FR7117104 A FR 7117104A FR 7117104 A FR7117104 A FR 7117104A FR 2100660 A1 FR2100660 A1 FR 2100660A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7117104A
Other languages
French (fr)
Other versions
FR2100660B1 (enExample
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck et Cie
Merck and Co Inc
Original Assignee
Merck et Cie
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck et Cie, Merck and Co Inc filed Critical Merck et Cie
Publication of FR2100660A1 publication Critical patent/FR2100660A1/fr
Application granted granted Critical
Publication of FR2100660B1 publication Critical patent/FR2100660B1/fr
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
FR7117104A 1970-05-15 1971-05-12 Expired FR2100660B1 (enExample)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3789670A 1970-05-15 1970-05-15

Publications (2)

Publication Number Publication Date
FR2100660A1 true FR2100660A1 (enExample) 1972-03-24
FR2100660B1 FR2100660B1 (enExample) 1975-06-06

Family

ID=21896942

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7117104A Expired FR2100660B1 (enExample) 1970-05-15 1971-05-12

Country Status (15)

Country Link
US (1) US3666646A (enExample)
AR (1) AR199872A1 (enExample)
BE (1) BE767190A (enExample)
CA (1) CA985677A (enExample)
DE (1) DE2124123A1 (enExample)
ES (1) ES391016A1 (enExample)
FR (1) FR2100660B1 (enExample)
GB (1) GB1355516A (enExample)
HU (1) HU164639B (enExample)
IE (1) IE35215B1 (enExample)
IL (1) IL36772A0 (enExample)
NL (1) NL7105076A (enExample)
NO (1) NO131754B (enExample)
SU (1) SU421202A3 (enExample)
ZA (1) ZA712259B (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0113162B1 (en) * 1982-09-16 1989-07-19 Hem Research, Inc. Anti-proliferative action of dsnras on tumor cells
ATE299885T1 (de) 1999-02-15 2005-08-15 Nippon Shinyaku Co Ltd Polynukleotide mit gekürzter kette und verfahren zu ihrer herstellung
CA2587676A1 (en) * 2004-11-19 2006-05-26 Institut Gustave Roussy Improved treatment of cancer by double-stranded rna
DK1898948T3 (da) * 2005-06-08 2012-04-23 Yisheng Biopharma Singapore Pte Ltd Polyriboinosinsyre-polyribocytidylsyre-baseret adjuvans
US20070166239A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Mucosal immunogenic substances comprising a polyinosinic acid - polycytidilic acid based adjuvant
US20070166800A1 (en) * 2006-01-13 2007-07-19 Haixiang Lin Immunogenic substances comprising a polyinosinic acid-polycytidilic acid based adjuvant
EP2116602A1 (en) 2008-05-07 2009-11-11 Institut Gustave Roussy Combination products for treating cancer
EP2542670A2 (en) 2010-03-05 2013-01-09 President and Fellows of Harvard College Induced dendritic cell compositions and uses thereof
WO2016105274A1 (en) 2014-12-23 2016-06-30 Yisheng Biopharma (Singapore) Pte Ltd A rabies composition comprising pika adjuvant
CA3213217A1 (en) 2021-04-28 2022-11-03 Raphael Darteil Strong potentiation of tlr3 agonists effects using fxr agonists as a combined treatment

Also Published As

Publication number Publication date
ZA712259B (en) 1972-11-29
ES391016A1 (es) 1974-04-01
CA985677A (en) 1976-03-16
IE35215B1 (en) 1975-12-10
IE35215L (en) 1971-11-15
AR199872A1 (es) 1974-10-08
IL36772A0 (en) 1971-07-28
NL7105076A (enExample) 1971-11-17
HU164639B (enExample) 1974-03-28
BE767190A (fr) 1971-11-16
SU421202A3 (ru) 1974-03-25
US3666646A (en) 1972-05-30
DE2124123A1 (de) 1971-12-02
NO131754B (enExample) 1975-04-14
GB1355516A (en) 1974-06-05
FR2100660B1 (enExample) 1975-06-06

Similar Documents

Publication Publication Date Title
AR204384A1 (enExample)
FR2100660B1 (enExample)
ATA96471A (enExample)
AU1473870A (enExample)
AU1146470A (enExample)
AU1336970A (enExample)
AU1326870A (enExample)
AU1004470A (enExample)
AU1328670A (enExample)
AU2131570A (enExample)
AU1277070A (enExample)
AU1247570A (enExample)
AU1235770A (enExample)
AU1189670A (enExample)
AU1343870A (enExample)
AU2144270A (enExample)
AU2154470A (enExample)
ATA672271A (enExample)
AU2112570A (enExample)
AU1086670A (enExample)
AU1083170A (enExample)
AU1064870A (enExample)
AU2115870A (enExample)
CH565208A5 (enExample)
CH545797A (enExample)

Legal Events

Date Code Title Description
ST Notification of lapse